Seeking long-term growth opportunities among the old & new in ASEAN
ASEAN is gaining momentum with its mix of old & new economies.
How smart can a pen be2 ?
Pens are no longer used only for writing in the healthcare sector. And some pens have become smarter.
Innovative medical devices such as a smart, reusable insulin pen2 is improving the quality of life for patients with diabetes. It’s a pen that offers quick and relatively painless injections, can calculate and track doses as well as provide reminders, alerts and reports. When connected to a smartphone app, the pen could also help diabetics better monitor their blood sugar levels, diet and exercise. The data on the pen could also help doctors and patients make optimial treatment decisions.
Additionally, some healthcare companies are using data science and artificial intelligence for new medicines and timely diagnosis. Such breakthrough in treatments and innovative technologies are presenting long-term growth opportunities in the healthcare sector.
Investing in healthcare - same, same but different1
What to keep in mind
A digital transformation of healthcare is taking place across all members of the Organization for Economic Co-operation and Development (OECD) grouping, accelerated by the public health crisis and driven up by digitisation of IT infrastructure as well as growing demand from patients3. Additionally, a rapid rise in demand among emerging markets could help accelerate the sector’s long-term growth.
Forward P/E of US healthcare sectors and the S&P 5004
Governments and companies have accelerated investments in healthcare, including sub-sectors such as innovative medical technologies, biotechnology, pharmaceuticals and new medical devices and services. As illustrated in the chart4, these various healthcare sub-sectors, where valuation remains relatively attractive, are presenting long-term growth opportunities.
The global public health crisis has brought healthcare to the forefront, presenting long-term growth opportunities in sub-sectors such as innovative medical technologies, biotechnology, pharmaceuticals as well as new medical devices and services. Additionally, the growing middle class in emerging markets and an ageing population could help accelerate demand and the sector’s long-term growth.